Lataa...
Inflammation, but not hypoxia, mediated HIF-1α activation depends on COX-2
The COX pathway has been a target for pharmaceutical intervention in diseases with a high inflammatory component ranging from asthma and Alzheimer's to arthritis and cancer. A major transcriptional promoter of the malignant phenotype, HIF-1α, has been observed to be regulated by the COX-2 produ...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3058789/ https://ncbi.nlm.nih.gov/pubmed/19390242 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|